Reduction of thermal conductivity by nanopillar inclusion in thermoelectric vertically aligned nanocomposites by Marijn W van de Putte, Jasman Singh Gambhir, Nicolas Gauquelin, Alexandros Sarantopoulos, Daniel Monteiro Cunha, Johan Verbeeck, Gertjan Koster, Francisco Rivadulla, Mark Huijben

Get full text

Reflection on clinical and methodological issues in rare disease clinical trials. by Johan Verbeeck, Martin Geroldinger, Joakim Nyberg, Konstantin E. Thiel, Andrew C. Hooker, Arne C. Bathke, Johann W. Bauer, Geert Molenberghs, Martin Laimer, Georg Zimmermann

Get full text

Al2O3/Al hybrid nanolaminates with superior toughness, strength and ductility by Paul Baral, Sahar Jaddi, Hui Wang, Andrey Orekhov, Nicolas Gauquelin, Alireza Bagherpour, Frederik Van Loock, Michaël Coulombier, Audrey Favache, Morgan Rusinowicz, Johan Verbeeck, Stéphane Lucas, Jean-Pierre Raskin, Hosni Idrissi, Thomas Pardoen

Get full text

Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study by Hector Gonzalez Dorta, MSc, Johan Verbeeck, PhD, Jonas Crevecoeur, PhD, Daniel R Morales, PhD, Neilshan Loedy, MSc, Catherine Cohet, PhD, Lander Willem, PhD, Geert Molenberghs, ProfPhD, Niel Hens, ProfPhD, Xavier Kurz, PhD, Chantal Quinten, PhD, Steven Abrams, PhD

Get full text